Get started
Author

Manzer Ali

Efficacy of herbicides in controlling Parthenium hysterophorus L. in spring maize (Zea mays L.)
2016 · A. Rehman, F.U. Hassan, et al. · Quality Assurance and Safety of Crops & Foods · 4
Case study: The effect of wheat density and cultivar on growth and reproduction of burr medic (Medicago polymorpha L.), wheat growth, and yield
2021 · Mubarak Ali, Asad Shabbir, et al. · Weed Biology and Management · 2
Impact of tumor sidedness and social determinants of health on survival in early-onset colon cancer: A SEER 2004–2022 study.
2026 · Tayyaba Saleem, Manzer Ali, et al. · Journal of Clinical Oncology · 1
PDF
Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): A faers disproportionality study, 2014–2025
2025 · Aftab Ahmed, Rajesh Thirumaran, et al. · Blood · 1
AML-1136: Survival Disparities in De Novo Versus Secondary Acute Myeloid Leukemia: A 20-Year Population-Based Analysis of 64,624 United States Adults
2025 · Manzer Ali, Hanzala Jehangir, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
AML-1244: Geographic and Socioeconomic Stratification of Novel Therapy Survival Benefit in Older Adults With Acute Myeloid Leukemia: A Population-Based Analysis of the SEER Registry, 2010–2022
2026 · Manzer Ali, Hanzala Jahangir, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1244: Geographic and Socioeconomic Stratification of Novel Therapy Survival Benefit in Older Adults With Acute Myeloid Leukemia: A Population-Based Analysis of the SEER Registry, 2010–2022
2026 · Manzer Ali, Hanzala Jahangir, et al. · Clinical Lymphoma Myeloma & Leukemia
Stage distribution, treatment patterns, and stage-specific survival in Merkel cell carcinoma before and after the immunotherapy era: A SEER analysis (2004–2022).
2026 · Renu Bhargavi Boyapati, Sai Samyuktha Bandaru, et al. · Journal of Clinical Oncology
Incidence, survival, and persistent age and sex disparities in uveal melanoma: A SEER population study (2000–2022).
2026 · Renu Bhargavi Boyapati, Sai Samyuktha Bandaru, et al. · Journal of Clinical Oncology
PDF
Breast Cancer Recurrence After 46 Years of Remission: A Case Report and Clinical Implications
2026 · HEENA PARKASH, AARIFAH BANDEALY, et al. · In Vivo
PDF
26-a-13743-acc Is Immunotherapy Driving the Post-2013 Surge in Cardiac Mortality Among U.s. Adults Aged >55 With Malignancy? an Arima - Based Cdc Wonder Analysis (1999-2023)
2026 · Hanzala Jehangir, Gamal Musleh, et al. · Journal of the American College of Cardiology
Abstract 4369138: 25-Year Decline in Aortic Aneurysm and Dissection Mortality in the U.S.: Impact of Endovascular Repair and Forecast to 2030
2025 · Manzer Ali, Ayesha Sharif, et al. · Circulation
Increased risk of gastrointestinal complications in older adults with multiple myeloma: A propensity matched nationwide cohort study
2025 · Kirti Arora, Rishi Chowdhary, et al. · Blood
Real-world survival trends in smoldering versus symptomatic multiple myeloma: A SEER analysis, 2012–2020
2025 · Manzer Ali, Bolivia Fernandes, et al. · Blood
Early versus late onset hematologic immune-related adverse events following immune checkpoint inhibition: Temporal patterns, clinical profiles, and risk stratification in faers reports (2014–2025)
2025 · Aftab Ahmed, Manzer Ali, et al. · Blood
PDF
Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach
2025 · Manzer Ali, Bolivia Fernandes, et al. · Blood
Cardiovascular safety profile of CD20 × CD3 bispecific antibodies compared to immune-checkpoint inhibitors: A faers analysis, 2014–2025
2025 · Manzer Ali, Zayd Parekh, et al. · Blood
PDF
Bayesian diagnostic test accuracy meta-analysis of ¹⁸F-FDG PET/CT for detecting Richter's transformation in chronic lymphocytic leukemia
2025 · Hanzala Jehangir, Muhammad Arham, et al. · Blood
Safety and efficacy of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory B-cell lymphomas: A systematic review and meta-analysis
2025 · Hanzala Jehangir, Sara Sharif, et al. · Blood
PDF
Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020
2025 · Manzer Ali, Kashish Magnani, et al. · Blood
Evolving prognostic impact of B symptoms in non-Hodgkin lymphoma: A competing-risks analysis of SEER data, 2010–2019
2025 · Manzer Ali, Saad Rashid, et al. · Blood
PDF
Racial disparities in lymphoma: Meta-analytic insights into diagnosis and survival gaps
2025 · Hanzala Jehangir, Muhammad Arham, et al. · Blood
Age at diagnosis shapes stage and survival in diffuse large B-cell lymphoma: A 22-year, population-based study of 94,598 SEER patients
2025 · Aftab Ahmed, Rajesh Thirumaran, et al. · Blood
PDF
Signal-rich and signal-poor: Divergent detection of early bacterial sepsis and latent viral complications after hematopoietic stem cell transplantation in the FDA adverse event reporting system
2025 · Manzer Ali, Bolivia Fernandes, et al. · Blood
PDF
Risk of thrombotic and bleeding events in patients with MPNs - does SSRI use have an impact?
2025 · Kirti Arora, Priyansh Faldu, et al. · Blood
PDF
Works count: 49
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type